Champions Oncology

About:

Champions Oncology develops advanced technology solutions and services for personalizing the development and use of oncology drugs.

Website: http://www.championsoncology.com

Twitter/X: champsonco

Top Investors: New Enterprise Associates, Perceptive Advisors, Battery Ventures, Sabby Capital, Dan Mendelson

Description:

Champions Oncology was founded by some of the world’s most renowned specialists in the field of cancer diagnosis, treatment, and research. Our team is comprised of seasoned oncology professionals passionately dedicated to working with you to accelerate oncology drug development, improve outcomes and extend lives. Our core platform, the Champions TumorGraft™ offers an enhanced xenograft mouse avatar model for growing and testing human tumors.

Total Funding Amount:

$36.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hackensack, New Jersey, United States

Founded Date:

1985-01-01

Founders:

David Sidransky

Number of Employees:

51-100

Last Funding Date:

2015-03-12

IPO Status:

Public

Industries:

© 2025 bioDAO.ai